In review of all case details against the criteria set forth in document (b)(4) (medical device reporting standard operating procedure) and its applicable appendices, this complaint does not meet the requirements for an mdr in the countries where the device is sold or distributed.However, the mdr is being submitted to us fda pursuant to the obligations of the emergency use authorization, and per communication received from fda on october 7, 2020.
|
The customer reported that they have a sample which generated an invalid result, and upon repeat from extraction, it generated 7 pos calls (including flu a and flu b).The third repeat from a new extraction generated an invalid result.The sample in question was run on an alternate assay (genmark) and it generated a neg call.
|